TickerFactsScreenerDevelopers

PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2002: $11.72M2003: $10.25M2004: $9.16M2005: $14.39M2006: $15.52M2007: $14.83M2008: $10.06M2009: $9.41M2010: $10.70M2011: $10.02M2012: $4.39M2013: $6.63M2014: $25.19M2015: $16.32M2016: $3.47M2017: -$10.02M2018: -$17.42M2019: -$24.07M2020: -$30.21M2021: -$4.19M2022: -$6.23M2023: -$7.59M2024: -$5.96M2025: -$6.30M-$6.30M
2002Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025-$6.30M-5.7%
2024-$5.96M+21.5%
2023-$7.59M-21.9%
2022-$6.23M-48.7%
2021-$4.19M+86.1%
2020-$30.21M-25.5%
2019-$24.07M-38.2%
2018-$17.42M-73.8%
2017-$10.02M-388.8%
2016$3.47M-78.7%
2015$16.32M-35.2%
2014$25.19M+280.0%
2013$6.63M+50.9%
2012$4.39M-56.2%
2011$10.02M-6.4%
2010$10.70M+13.7%
2009$9.41M-6.5%
2008$10.06M-32.2%
2007$14.83M-4.5%
2006$15.52M+7.9%
2005$14.39M+57.0%
2004$9.16M-10.6%
2003$10.25M-12.6%
2002$11.72M—